Digital Health Global

JANUARY 8, 2024

AI-powered* platform takes eCOA off the critical path to study startup for life sciences industry PALO ALTO, Calif.–(BUSINESS Early application of the technology in electronic clinical outcomes assessment (eCOA) deployments – a major delay to study startup industry-wide – is groundbreaking.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Digital Health Global

APRIL 16, 2024

Innovative and flexible, Medable Total Consent helps our industry move beyond simply relying on traditional paper consents.” Its digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure. Renal Care.

Drug Development 88

Drug Development Pharmaceuticals Health science Digital Health 88

Digital Health Global

JUNE 13, 2023

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Digital Health Global

MAY 10, 2023

The healthcare industry is experiencing a significant transformation, with technology playing a vital role in modernizing medical practices and enhancing health outcomes. Patient experience has become a primary focus in our industry, and the digital transformation has provided new ways to enhance it.

Patient Experience 167

Patient Experience Mobile Health Telemedicine Drug Development 167

Digital Health Global

SEPTEMBER 27, 2023

About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. ALSP’s portfolio companies are backed by renowned life science investors and are comprised of industry-leading, transformative companies, including KayoThera, Inc.,

Life Science 88

Life Science Drug Development HC BioTech 88

Lloyd Price

NOVEMBER 21, 2023

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. b) Build: develop new products for the 4P's? Subscribe Today!

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Lloyd Price

DECEMBER 11, 2023

Health Tech founder and M&A Advisor Lloyd Price believes virtual care can bring a sweep of benefits, but cautions that it will still need to find a way through barriers around access and affordability for patients, the security of patient data and the licensing of healthcare providers to practice across geographical and care boundaries.

Pharmaceuticals 64

Pharmaceuticals Digital Health Drug Development Life Science 64

Digital Health Global

JANUARY 31, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment of on average of $500K in Phase 2 and $1.5M in Phase 3.

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Lloyd Price

MAY 2, 2024

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

healthcare technology 67

healthcare technology Drug Development Leadership Digital Health 67

Health Populi

APRIL 29, 2019

In the past couple of months, Amazon announced many health-related plans and developments, including: Accepting medical and health savings accounts (HSAs) to pay for consumer health products like over-the-counter drugs. See more on that recommendation, and subsequent social media frenzy, here on Health Populi ).

HIPAA 305

HIPAA Drug Development Digital Health Mental health 305

Digital Health Global

NOVEMBER 2, 2023

I addressed six challenges in the healthcare industry, starting with unhealthy lifestyles. Digital Therapeutics (DTx) have proven effective in supporting lifestyle changes. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. DiMasi, H.G.

Drug Development 88

Drug Development Pharmaceuticals Public Health Telehealth 88

Lloyd Price

JUNE 17, 2023

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

Digital Health 81

Digital Health Drug Development Telemedicine Telehealth 81

Lloyd Price

FEBRUARY 20, 2020

At Mangrove, we believe digital health represents one of the very largest opportunities for value creation. It will also explain the value of clinically- proven software interventions, while dispelling the myth that doctors are better placed to build digital health businesses.

mHealth 83

mHealth Drug Development Digital Health 83

Healthcare IT News - Telehealth

MAY 29, 2020

“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. THE LARGER CONTEXT. She cites examples such as Binah.ai ON THE RECORD.

Mental health 136

Mental health Drug Development Pharmaceuticals Telehealth 136

Society for Participatory Medicine

JANUARY 27, 2022

The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care. Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users.

BioTech 107

BioTech Life Science Drug Development Patient Experience 107

Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science 87

Life Science Drug Development Digital Health Health IT 87

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.” Find out more: www.sanofiventures.com.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Digital Health Global

APRIL 10, 2023

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Co-Founder & President, and Chief Executive Officer.

Life Science 88

Life Science BioTech Drug Development Health science 88

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. Another example is CliniScout Recruit by Healthware – a digital service for recruiting subjects to clinical trials.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Healthcare Innovation Consortium

OCTOBER 24, 2023

We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded.

BioTech 60

BioTech Drug Development Healthcare Innovation Medical Technology 60

Lloyd Price

FEBRUARY 18, 2024

Mergers and acquisitions: The promising future of GLP-1s led to several mergers and acquisitions within the healthtech industry. These deals aimed to consolidate market share, expand research capabilities, and accelerate product development, further stimulating investor interest. Subscribe Today! Subscribe Today!

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Healthcare IT Today

JULY 25, 2022

AI/ML is revolutionizing the healthcare industry,” said Schiess. The most advanced teams spend precious time developing internal tools to tackle aspects of this issue, but rarely have the staff, focus or time to create a comprehensive solution. But in order for an AI system to work, datasets must be complete, and they must be accurate.

Life Science 84

Life Science Drug Development Digital Health Health Data 84

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. in 2060.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

Lloyd Price

FEBRUARY 2, 2024

Enhanced research efficiency: Researchers can gain faster access to anonymized patient data with patient consent through SSI, accelerating research efforts and drug development. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data 64

Health Data Interoperability healthcare technology Leadership 64

Xealth

JUNE 27, 2023

David Slifka, Vice President, Commercial Enablement The digital health ecosystem is a complex place. Confusion abounds among healthcare providers regarding digital therapeutics (DTx) terminology and classifications, and understandably so. DTx fall within the digital medicine subset within the larger digital health ecosystem.

Digital Health 52

Digital Health Drug Development Pharmaceuticals EHR 52

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 167

Drug Development Pharmaceuticals Life Science Digital Health 167

The Digital Health Corner

MARCH 26, 2018

In this scenario, a patient can digitally determine who should have access to the medical record (and which portion), which person(s) or entities saw or modified the record (and what portion) and when. Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health.

Digital Health 117

Digital Health Interoperability Life Science Healthcare Data Security 117

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Waracle

JANUARY 5, 2022

2021 has been a historic year for healthcare… and technology has been a crucial piece of the puzzle when it comes to keeping the healthcare industry resilient in the face of the challenges it has seen. . In fact, Exscientia stands by the claim that all drugs in the future will be made using AI. .

Patient Experience 36

Patient Experience Drug Development Digital Health Remote care 36

Digital Health Wire

NOVEMBER 5, 2023

However, generative AI products that respond to human queries require “a vastly different paradigm” to regulate, and FDA Digital Health Director Troy Tazbaz believes any new structure will involve ongoing audits to ensure continuous safety. The post AI Executive Order, the Full Breakdown appeared first on Digital Health Wire.

Drug Development 52

Drug Development Digital Health 52

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Healthcare IT News - Telehealth

MAY 6, 2020

In an age when nearly everyone is digitally connected in some way – even many senior citizens, who are often characterized as technophobic – it only makes sense that the healthcare industry is seeing a lot of connected health devices and remote patient monitoring (RPM) technologies. Bardy Diagnostics.

Connected Health 183

Connected Health Telehealth Pharmaceuticals EHR 183